Key result
Sustained systemic inflammation triggers myocardial transcriptional changes but causes no structural or functional cardiac differences.
Why the study?
Patients with rheumatoid arthritis have an elevated risk of heart failure, but the mechanisms involving cardiac structural and molecular alterations due to chronic inflammation are incompletely understood.
Does sustained systemic inflammation induced by a modified DTHA protocol reduce left ventricular function or induce cardiac remodeling in mice?
Does sustained systemic inflammation induced by a modified DTHA protocol reduce left ventricular function or induce cardiac remodeling in mice?
In a murine model, sustained systemic inflammation drives a pronounced myocardial inflammatory transcriptional response without progressing to overt structural or functional cardiac dysfunction over 8 weeks.
Systemic inflammation induces myocardial transcriptional changes without cardiac dysfunction in mice; leaves open its role in rheumatoid arthritis-associated heart failure.
Patients with rheumatoid arthritis (RA) face an elevated risk of developing heart failure, but the underlying mechanisms remain incompletely understood. Plausible causes include cardiac structural and molecular alterations attributable to sustained chronic inflammation. The present study investigates such putative cardiac alterations in a modified delayed-type hypersensitivity arthritis (DTHA) mouse model of sustained, RA-like inflammation. An RA-like inflammatory phenotype was induced in male BALB/c mice (n = 13) using a modified DTHA protocol, while control mice received vehicle injections (n = 13). The standard DTHA protocol consists of (1) immunization towards methylated bovine serum albumin (mBSA), (2) intravenous administration of a mixture of anti-collagen II antibodies, and (3) induction of arthritis via subcutaneous hind-leg injection of mBSA. In the modified DTHA protocol, steps 2 and 3 were repeated weekly for eight consecutive weeks to sustain inflammation. Analyses included serial cardiac magnetic resonance imaging (MRI, days 15 and 57), plasma inflammatory markers, the left ventricular (LV) myocardial transcriptome, and assessment of hypertrophic and fibrotic remodelling. Fluctuating, yet sustained local and systemic inflammation was demonstrated. Despite this, no structural or functional differences were detected by cardiac MRI, and no gross fibrotic or hypertrophic alterations were observed. However, RNA-sequencing of bulk LV myocardial tissue revealed a distinct transcriptional profile with marked enrichment of inflammatory signalling pathways. Despite preserved cardiac structure and function, mice subjected to sustained DTHA-driven systemic inflammation displayed a pronounced myocardial inflammatory transcriptional signature. Whether this observation represents an early state of cardiac vulnerability preceding overt dysfunction, possibly requiring additional cardiac stressors, remains a hypothesis to be tested.
No takes yet. Share an insight, caveat, or question.
Tønnessen et al. (2026) studied Systemic inflammation in a murine arthritis model (n=26). Modified delayed-type hypersensitivity arthritis (DTHA) protocol vs. Vehicle (phosphate-buffered saline) was evaluated on Left ventricular ejection fraction (LVEF) (MD -0.2% points, 95% CI -3.3 to 2.9). Sustained DTHA-driven systemic inflammation induced a myocardial inflammatory transcriptional signature but no structural or functional cardiac differences (LVEF difference -0.2%, 95% CI -3.3 to 2.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: